Natalizumab Alternatives Compared
Natalizumab | Entyvio | Pentasa |
|
---|
Natalizumab | Entyvio (vedolizumab) | Pentasa (mesalamine) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Sclerosis, Crohn's Disease - Maintenance. natalizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Entyvio infusion is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically... View more |
Prescription only
Prescribed for Crohn's Disease - Maintenance, Inflammatory Bowel Disease, Ulcerative Colitis, Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance, Ulcerative Proctitis. Pentasa may also be... View more |
Related suggestions Crohn's Disease, Maintenance
|
|||||||||||||||
More about Natalizumab | More about Entyvio (vedolizumab) | More about Pentasa (mesalamine) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Natalizumab has an average rating of 7.8 out of 10 from a total of 102 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
Entyvio has an average rating of 6.1 out of 10 from a total of 152 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 29% reported a negative effect. |
Pentasa has an average rating of 7.8 out of 10 from a total of 88 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: natalizumab side effects in more detail. |
See also: Entyvio side effects in more detail. |
See also: Pentasa side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Entyvio prices |
View all Pentasa prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Tyruko, Tysabri | Other vedolizumab brands include: Entyvio Pen | Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Lialda, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
360 hours |
600 hours |
10 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 405 drugs are known to interact with natalizumab:
|
A total of 152 drugs are known to interact with Entyvio:
|
A total of 120 drugs are known to interact with Pentasa:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
May 20, 2014 |
May 10, 1993 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.